Streptococcus pneumoniae Antigen, Urine
Streptococcus pneumoniae (pneumococcus) is a Gram-positive diplococcus characterized by its prominent polysaccharide capsule. Although commonly colonizing the upper respiratory tract as part of normal flora, pneumococcus can cause invasive and serious infections such as pneumonia, meningitis, acute otitis media, sinusitis, and bloodstream infections (bacteremia/sepsis).
The pneumococcal capsule comprises over 90 distinct serotypes, differentiated by antigenic variations in polysaccharide capsule structures. These polysaccharides elicit robust T-cell-independent (Type II) humoral immune responses leading to the production of protective IgG antibodies, offering long-term immunologic memory.
Due to their potent immunogenicity, pneumococcal polysaccharides from 23 prevalent serotypes causing invasive diseases are utilized in the Pneumococcal Polysaccharide Vaccine 23 (PPSV23). This vaccine effectively induces protective IgG antibodies in approximately 75–85% of vaccinated individuals within 4–6 weeks post-immunization.
Quantitative measurement of IgG antibodies against these 23 serotypes is clinically useful for diagnosing pneumococcal infections and assessing the immunogenic response following vaccination with PPSV23.
- Aid in the diagnosis of Streptococcus pneumoniae infections
- Evaluation of immune response and antibody-mediated protection following PPSV23 vaccination
≥ 1.0 mcg/mL
Serum (SST tube)
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 14 days
- Clin Immunol Immunopathol. 1987 Jul;44(1):114-21. [PMID: 3297436]
- FEMS Microbiol Rev. 2017 Nov 1;41(6):854-879. [PMID: 29029129]
- Vaccine. 2024 Apr 2;42(9):2448-2454. [PMID: 38458872]
- J Infect Dis. 1990 Aug;162(2):482-8. [PMID: 2373875]